Want to see TSE:OGO full AI Analyst Report?
Top Page
Organto Foods
(OGO)
Select Model
Select Model
Rating:47Neutral
Price Target:
C$0.36
▼(-35.71% Downside)
Action:Reiterated
Date:10/21/26
The score is held back primarily by weak financial quality (ongoing losses and sustained negative operating/free cash flow) and bearish technicals (price below major moving averages with negative MACD). The earnings call provides a meaningful offset with strong sales momentum, improving gross profit, and recent EBITDA positivity, while valuation remains constrained by loss-making results and no dividend support.
Positive Factors
Strong Sales Growth
Rapid sales growth indicates expanding commercial traction across Organto’s European platform and customer base. If sustained, the larger revenue base can improve purchasing scale, support overhead absorption, and provide a foundation for stronger earnings over the next several quarters.
Negative Factors
Persistent Cash Burn
Persistent negative operating and free cash flow means revenue growth has not yet converted into internally generated liquidity. Continued cash burn could increase reliance on financing or working-capital facilities and limit the company’s ability to fund expansion without improving profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Sales Growth
Rapid sales growth indicates expanding commercial traction across Organto’s European platform and customer base. If sustained, the larger revenue base can improve purchasing scale, support overhead absorption, and provide a foundation for stronger earnings over the next several quarters.
Read all positive factors
Organto Foods (OGO) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$51.66M
Dividend YieldN/A
Average Volume (3M)45.06K
Price to Earnings (P/E)―
Beta (1Y)0.30
Revenue Growth96.04%
EPS Growth63.06%
CountryCA
Employees40
SectorGeneral
Sector StrengthN/A
IndustryFood Distribution
Share Statistics
EPS (TTM)-0.06
Shares Outstanding149,726,910
10 Day Avg. Volume48,315
30 Day Avg. Volume45,061
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)13.17
Price to Sales (P/S)1.90
P/FCF Ratio-38.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.25Price Target Upside123.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.01
Revenue Forecast (FY)C$105.40M
Organto Foods Business Overview & Revenue Model
Company Description
Organto Foods Inc. manages the complete lifecycle of organic and value-added fruit and vegetable products, from sourcing and processing to packaging, distribution, and market sale. Their diverse product portfolio includes a variety of organic fres...
How the Company Makes Money
Organto Foods makes money primarily by generating revenue from the sale of organic and non-GMO food products through business-to-business distribution and related commercial arrangements. Key revenue streams have included (1) distribution/wholesal...
Organto Foods Earnings Call Summary
Earnings Call Date:Aug 11, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Dec 02, 2026
Earnings Call Sentiment Positive
The call highlights a clear turnaround with record revenue, strong gross-profit growth, two consecutive EBITDA-positive quarters, improved liquidity and notable operational expansion (new customers, geographies, centers of excellence and digital investments). Challenges cited include modest margin levels despite improvement, volatility in fuel and shipping costs, absolute overhead growth due to scaling, supply/quality execution risk, and no near-term M&A closures despite an active pipeline. On balance, achievements and positive operational and financial momentum materially outweigh the challenges.Positive Updates
Record Quarterly and Year-to-Date Sales
Q2 sales were a record $27.7M, up 61% year-over-year; year-to-date sales were $53.3M, up 73% YTD, placing the company on an annualized run rate above $100M (approx. $110M).
Negative Updates
Modest Gross and EBITDA Margins
Despite growth, gross profit margin remains modest at 7.5% of sales in Q2 and EBITDA margin at ~1.5% of sales; management continues to target margin improvement via product mix, pricing and supply-chain leverage.
Read all updates
Q2-2026 Updates
Positive
Negative
Record Quarterly and Year-to-Date Sales
Q2 sales were a record $27.7M, up 61% year-over-year; year-to-date sales were $53.3M, up 73% YTD, placing the company on an annualized run rate above $100M (approx. $110M).
Read all positive updates
Company Guidance
Management's guidance emphasizes execution to convert first‑half momentum into sustainable, profitable growth by scaling the European Fresh platform, selectively pursuing M&A (including North America), adding higher‑margin/non‑fresh and value‑added products, and accelerating digital/AI efficiency. Key metrics cited: an annualized sales run‑rate above $100M (Q2 sales $27.7M, +61%; YTD $53.3M, +73%), Q2 gross profit $2.1M (7.5% of sales, +65%; YTD $3.9M, 7.3%), Q2 EBITDA $400k (1.5% of sales) and YTD EBITDA $500k (vs −$200k prior year), a target to drive cash overheads to just below 5% of sales (longer‑term under 5%, aiming ~4%), and a strong balance sheet (cash $5.4M + $1.0M restricted, working capital $15.3M, current assets $27.5M, no long‑term debt, equity $16.4M; Rabobank facility increased to €7M). Management expects continued EBITDA‑positive quarters but gave no specific numeric forward guidance beyond these targets.Organto Foods Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
58
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Sep 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.31M | 60.84M | 20.70M | 27.68M | 22.12M | 19.52M |
| Gross Profit | 2.60M | 1.49M | 1.76M | 2.46M | 1.26M | 1.99M |
| EBITDA | -2.32M | -545.84K | -1.85M | -9.41M | -9.25M | -5.32M |
| Net Income | -9.47M | -16.82M | -4.54M | -13.43M | -10.83M | -6.34M |
Balance Sheet | ||||||
| Total Assets | 28.75M | 16.27M | 6.03M | 6.92M | 11.37M | 20.96M |
| Cash, Cash Equivalents and Short-Term Investments | 6.43M | 6.78M | 357.60K | 195.04K | 5.86M | 11.87M |
| Total Debt | 107.66K | 185.83K | 12.52M | 12.21M | 8.98M | 8.44M |
| Total Liabilities | 12.38M | 7.50M | 19.95M | 22.45M | 14.53M | 14.27M |
| Stockholders Equity | 16.38M | 8.77M | -13.91M | -15.54M | -3.16M | 6.69M |
Cash Flow | ||||||
| Free Cash Flow | -5.20M | -3.02M | -3.04M | -3.91M | -5.84M | -5.92M |
| Operating Cash Flow | -5.20M | -3.02M | -3.04M | -3.89M | -5.72M | -5.92M |
| Investing Cash Flow | 39.28K | -350.00K | -27.03K | -318.38K | -928.58K | -357.41K |
| Financing Cash Flow | 11.00M | 9.82M | 3.17M | -1.39M | -312.04K | 13.99M |
Organto Foods Technical Analysis
Negative
0.56
Price Trends
0.47
Negative
0.55
Negative
0.71
Negative
Market Momentum
-0.03
Negative
39.98
Neutral
56.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OGO, the sentiment is Negative. The current price of 0.56 is above the 20-day moving average (MA) of 0.40, above the 50-day MA of 0.47, and below the 200-day MA of 0.71, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 39.98 is Neutral, neither overbought nor oversold. The STOCH value of 56.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:OGO.
Organto Foods Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | C$51.66M | -6.00 | -76.61% | ― | 96.04% | 63.06% | |
47 Neutral | C$130.88M | -612.90 | 13.66% | ― | 36.59% | 43.33% | |
44 Neutral | C$491.47K | -6.62 | 290.24% | ― | ― | -29.09% | |
40 Underperform | C$13.40M | -3.00 | -210.36% | ― | -7.32% | 44.23% |
* General Sector Average
TSE:OGO
Organto Foods
0.35
-0.24
-40.52%
TSE:EBM
Eastwood Bio-Medical Canada
1.90
1.20
171.43%
TSE:EWG
Eat Well Investment Group Inc
0.08
-0.10
-55.88%
TSE:ZOG.X
Zoglo's Incredible Food Corp.
0.03
-0.02
-33.33%
TSE:FRSH
Fresh Factory B.C. Ltd.
0.75
-0.32
-29.91%
Organto Foods Corporate Events
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Organato Foods Posts Record First-Half Results and Tops $100 Million Sales Run Rate
Positive
Sep 28, 2026
Organto Foods reported record first-half 2026 sales of $53.3 million, up 73% year over year, alongside record adjusted gross profit and a swing to positive EBITDA. Management said the company has refocused its business, reorganized leadership and ...
Business Operations and StrategyFinancial Disclosures
Organto Foods Targets Growth at Madrid’s Fruit Attraction 2026
Positive
Sep 9, 2026
Organto Foods will participate in the Fruit Attraction 2026 trade show in Madrid from October 6 to 8, using the event to deepen relationships with retailers and suppliers and to pursue strategic partnerships. The company and its New Fruit Group su...
Business Operations and StrategyFinancial Disclosures
Organto Foods Delivers Record Q2 2026 Sales and EBITDA on Strong Organic Foods Growth
Positive
Aug 11, 2026
Organto Foods reported record second-quarter 2026 results, with sales climbing 61% year over year to $27.7 million, the highest in its history, and gross profit rising 65% to $2.1 million, or 7.5% of sales. Adjusted gross profit, including currenc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.